Skip to content

Macro- and Microvascular Response to Cocoa Flavanols in Healthy and Type 2 Diabetes

Proof-of-concept Study to Investigate Hand and Foot Microvascular Response to Cocoa Flavanols in Healthy and Type 2 Diabetes Participant

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05449782
Enrollment
22
Registered
2022-07-08
Start date
2021-05-17
Completion date
2022-05-17
Last updated
2022-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Stiffness, Healthy Participants, Microangiopathy, Diabetic, Optical Tomography, Polyphenol, Vascular Endothelium

Brief summary

The greatest challenge in our ageing society are cardiovascular diseases such as stroke, heart attack, peripheral artery disease of the legs with non-healing wounds (ulcers), or diabetes. Specific diets with high polyphenol content are associated with lower incidence of cardiovascular disease and can improve macrovascular function when consumed acutely and chronically. Which role the smallest blood vessels (microcirculation) play in this and if the microcirculation responds to therapies is not well understood. One reason for this is that no generally available medical instrument has the resolution to study the microcirculation. The recently developed optical coherence tomography angiography (OCTA), currently mainly used by eye doctors, is able to visualise the microcirculation. The current randomised controlled cross-over proof-of-concept study will test the acute effect of a cocoa flavanol intervention on cutaneous microvascular structure and function of hands and feet together with macrovascular function of upper and lower extremities in healthy and type 2 diabetes participants. It is the hypothesis that cocoa flavanol intervention as compared to placebo can acutely increase microvascular vasodilation and macrovascular endothelial function in arms and legs together with arterial stiffness in both healthy and type 2 diabetes participants.

Interventions

DIETARY_SUPPLEMENTCocoa flavanol

Commercially available Cocoa Via Brand capsules containing 1350 mg cocoa flavanols (6 capsules)

OTHERPlacebo

Capsules identical to ccocoa flavanol capsules filled with calorically matched brown sugar (6 capsules)

Sponsors

University of Surrey
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Placebo and cocoa flavanols will be delivered in same number of identical appearing capsules

Intervention model description

2 group (healthy and type 2 diabetes) randomised controlled cross-over (2-period, 2-sequence) study

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy: Inclusion Criteria: * Healthy, 20-70 years * BMI 20-30 kg/m\^2

Exclusion criteria

* Diabetes mellitus * Symptoms of acute infection * Cardiac rhythm other than sinus * Active malignancy * Clinical signs or symptoms of cardiovascular disease (coronary artery disease, lower extremity artery disease, cerebrovascular disease): angina pectoris, dyspnea, palpitation, syncope, claudication * Active vasoactive medication. Type 2 Diabetes: Inclusion Criteria: * Type 2 diabetes mellitus * 20-70 years * BMI 20-30 kg/m\^2

Design outcomes

Primary

MeasureTime frameDescription
Microvascular dilationChange at 2 hours as compared to baseline after ingestion of cocoa flavanol vs placeboMicrovascular diameter increase in response to 5 min limb occlusion on hands and feet
Macrovascular endothelial functionChange at 2 hours as compared to baseline after ingestion of cocoa flavanol vs placeboFlow-mediated dilation determined with ultrasound in brachial and common femoral artery

Secondary

MeasureTime frameDescription
Leg perfusion pressureChange at 2 hours as compared to baseline after ingestion of cocoa flavanol vs placeboDoppler based perfusion pressure of leg
Blood pressureChange at 2 hours as compared to baseline after ingestion of cocoa flavanol vs placeboUpper arm blood pressure measured with Arteriograph
Arterial stiffnessChange at 2 hours as compared to baseline after ingestion of cocoa flavanol vs placeboPulse wave velocity (Arteriograph)

Other

MeasureTime frameDescription
Photoplethysmography (PPG) based pulse wave velocity (PWV)Change at 2 hours as compared to baseline after ingestion of cocoa flavanol vs placeboPWV velocity calculated based on PPG sensor at hand and foot
Photoplethysmography (PPG) blood flowChange at 2 hours as compared to baseline after ingestion of cocoa flavanol vs placeboBased on PPG signals on hand and foot

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026